Evidence map›Paper›PMID 30944250›Full record

ArticleJCI insight2019

MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis.

Jun-Ichi Abe, Kyung Ae Ko, Sivareddy Kotla, Yin Wang, Jesus Paez-Mayorga, Ik Jae Shin, Masaki Imanishi, Hang Thi Vu, Yunting Tao, Miguel M Leiva-Juarez and 16 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Metabolic regulation of endothelial senescence.Frontiers in cardiovascular medicine · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 3 countries.

Jun-Ichi AbeDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kyung Ae KoDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Sivareddy KotlaDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yin WangDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jesus Paez-MayorgaCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
Ik Jae ShinDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Masaki ImanishiDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hang Thi VuDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yunting TaoCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
Miguel M Leiva-JuarezDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tamlyn N ThomasDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jan L MedinaDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jong Hak WonDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yuka FujiiDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Carolyn J GiancursioCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
Elena McBeathDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ji-Hyun ShinDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Liliana GuzmanCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
Rei J AbeCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
Jack TauntonDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California, USA.
Naoki MochizukiDepartment of Cell Biology, National Cardiovascular Center Research Institute, Osaka, Japan.
William FaubionDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
John P CookeCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
Keigi FujiwaraDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Scott E EvansDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nhat-Tu LeCenter for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Houston Methodist Research Institute, Houston Texas, USA.
The University of Texas MD Anderson Cancer Center · USHouston Methodist · USMayo Clinic · USNational Cerebral and Cardiovascular Center · JPUniversity of California, San Francisco · US

Funding

Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumoniaR35HL144805 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EVANS, SCOTT E. · 2019 to 2025
$6.2M
Inducible epithelial antiviral resistance to prevent asthmaDP2HL123229 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EVANS, SCOTT E. · 2013 to 2013
$2.4M
A Novel Role for MAGI1 in regulating non-canonical LATS signaling and atherosclerotic plaque formationR01HL134740 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LE, NHAT-TU · 2017 to 2021
$2.0M
Disturbed flow-induced TERF2IP post-translational modifications and atherosclerosis.R01HL130193 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI · 2016 to 2019
$2.0M
Epithelial mechanisms of inducible resistance to AML-associated pneumoniaR01HL117976 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EVANS, SCOTT E. · 2014 to 2018
$2.0M
p90RSK-ERK5 module, efferocytosis, and vulnerable plaque formationR01HL118462 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI · 2014 to 2018
$2.0M
Role of S-nitrosylation in TransdifferentiationR01HL133254 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI CHEN, KAIFU, COOKE, JOHN P · 2018 to 2021
$1.6M
NHLBI NIH HHS DP2 HL123229NHLBI NIH HHS R01 HL117976NHLBI NIH HHS R01 HL118462NHLBI NIH HHS R01 HL130193NHLBI NIH HHS R01 HL133254NHLBI NIH HHS R01 HL134740NHLBI NIH HHS R35 HL144805
6 · The paper itself

Abstract

The possible association between the membrane-associated guanylate kinase with inverted domain structure-1 (MAGI1) and inflammation has been suggested, but the molecular mechanisms underlying this link, especially during atherogenesis, remain unclear. In endothelial cells (ECs) exposed to disturbed flow (d-flow), p90 ribosomal S6 kinase (p90RSK) bound to MAGI1, causing MAGI1-S741 phosphorylation and sentrin/SUMO-specific protease 2 T368 phosphorylation-mediated MAGI1-K931 deSUMOylation. MAGI1-S741 phosphorylation upregulated EC activation via activating Rap1. MAGI1-K931 deSUMOylation induced both nuclear translocation of p90RSK-MAGI1 and ATF-6-MAGI1 complexes, which accelerated EC activation and apoptosis, respectively. Microarray screening revealed key roles for MAGI1 in the endoplasmic reticulum (ER) stress response. In this context, MAGI1 associated with activating transcription factor 6 (ATF-6). MAGI1 expression was upregulated in ECs and macrophages found in atherosclerotic-prone regions of mouse aortas as well as in the colonic epithelia and ECs of patients with inflammatory bowel disease. Further, reduced MAGI1 expression in Magi1-/+ mice inhibited d-flow-induced atherogenesis. In sum, EC activation and ER stress-mediated apoptosis are regulated in concert by two different types of MAGI1 posttranslational modifications, elucidating attractive drug targets for chronic inflammatory disease, particularly atherosclerosis.

Indexed as

Endoplasmic Reticulum StressActivating Transcription Factor 6Adaptor Proteins, Signal TransducingAdultAnimalsAortaApoptosisAtherosclerosisCell Adhesion MoleculesCells, CulturedColonCysteine EndopeptidasesDisease Models, AnimalEndothelial CellsEndothelium, VascularFemaleActivating Transcription Factor 6Adaptor Proteins, Signal TransducingAtf6 protein, mouseCell Adhesion MoleculesCysteine EndopeptidasesGuanylate KinasesMAGI1 protein, humanMagi1 protein, mouseRibosomal Protein S6 Kinases, 90-kDaSenp2 protein, mouseApoptosis pathwaysCardiologyCardiovascular diseaseCell BiologySignal transduction

Identifiers

PMID30944250
PMCPMC6483653
OpenAlexW2934397599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.